Quote | Foundation Medicine Inc. (NASDAQ:FMI)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | Foundation Medicine Inc. (NASDAQ:FMI)
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three independent directors to it...
Introduction We present here some results of a study on U.S. listed companies in the healthcare sector (Nasdaq, NYSE and Amex) based on their patent activity based on PCT (Patent Cooperation Treaty) patent applications administered by the World Intellectual Property Office (WIPO). We have sh...
Message Board Posts | Foundation Medicine Inc. (NASDAQ:FMI)
|Roche acquires majority stake in FMI @$50/sh||PennyStock Alert||investorshub||09/16/2019 1:04:06 PM|
|Congrats to all long!!!||Cheetah SPEED||investorshub||06/19/2018 1:14:34 PM|
|$FMI buy 74.90||stocktrademan||investorshub||02/19/2018 10:34:46 PM|
|$FMI PR on FDA/CMS approval of FoundationOne CDx:||DewDiligence||investorshub||12/01/2017 6:35:27 PM|
|Looks like serious competition for $FMI: #msg-136227022.||DewDiligence||investorshub||11/15/2017 7:04:09 PM|
Foundation Medicine Inc. Company Name:
FMI Stock Symbol:
Foundation Medicine Inc. Website:
News, Short Squeeze, Breakout and More Instantly...